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Human milk (HM) contains critical nutrients and possibly other neurotrophic factors that could benefit the less
developed brain of preterm infants, particularly those with very low birth weight (VLBW). This study aims to
systematically review the original studies to determine whether there is a reproducible independent effect of HM
feeding on neurodevelopment outcome in preterm VLBW infants. Search of seven databases (PubMed, Cochrane,
CINAHL, Embase, Proquest Research Library, Google Scholar, and Web of Science) identified 24 original studies. Each
study was evaluated by two authors independently for 8 non-nutritive (study design, target population, a priori
power calculation, adjustment for baseline growth status, postnatal complication, other confounders, observer
blinding to feeding status, effect size) and 5 nutritive (definition and duration of HM intake, use of HM fortifier,
source of HM data, infant formula used) methodology parameters, and consistency and directness of outcome
measures. Thirteen reports of preterm infants with wide ranges of birth weights were excluded as none provided
sufficient data to delineate the effects of HM feeding on developmental outcome of subjects with VLBW. Eleven
reports included only VLBW children and 7 studies were reviewed after elimination of preliminary data from same
cohort or lack of appropriate standardized testing or control group. These 7 studies (n = 18 to 704, median 219)
were performed at <3 years (3 studies) and at 5 to 11 years (4 studies). Six studies were secondary analysis of data
from other studies. Each study met or only partially met 4 to 10 methodological parameters. VLBW children with no
neurological impairment fed HM achieved normal or low normal range of test scores. Formula feeding using older
formulations was associated with a lower subtest score in 4 studies. There is no randomized clinical trial comparing
the neurodevelopment outcome of HM versus formula or minimal HM feeding that included only children with
VLBW. The role of HM in the neurodevelopment and cognitive function of VLBW children needs reassessment with
high quality studies in the context of current formulations of HM fortifier and preterm formula.
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functionIntroduction
Preterm very low birth weight (VLBW, <1,500 g) infants
are at high risk for growth failure and co-morbidities
that result in delayed neurodevelopment and academic
achievement [1-3]. Early nutrition support is recognized
as critical to growth and development and exclusive
breastfeeding is universally recommended as beneficial
to the health and well-being for all infants [4-6]. How-
ever, human milk (HM) alone does not support optimal
growth for VLBW infants, so multinutrient fortification,* Correspondence: wkoo@lsuhsc.edu
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unless otherwise stated.focusing on protein, minerals, vitamins and other nutri-
ents is recommended [4-6]. Preterm VLBW infants are
born at a period of significant phase of in utero organ
development and are at risk for deficiency of essential
nutrients and trophic factors critical to the growth and
function of the nervous system. The less developed brain
of preterm infants, particularly those with VLBW, theo-
retically could benefit from feeding maternal milk since
it contains critical nutrients such as long chain poly-
unsaturated fatty acids (LCPUFA) and possibly other
neurotrophic factors. This is supported by a review of
earlier studies which indicated that HM has greater neu-
rodevelopment benefits than formula for feeding pre-
term infants [7].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ation of the effect of feeding HM on neurodevelopment
outcome. Since it is neither feasible nor ethical to assign
breastfeeding randomly, determining the effect of breast-
feeding is invariably based on observation. This has chal-
lenges particularly in controlling for factors to minimize
the risk of bias [8-10]. One quasi-randomized trial in pre-
term infants of varying birth weights and gestational ages
showed significant neurodevelopment benefit for infants
fed HM [11]. This and other reports [7], did not ad-
equately control for perinatal and postnatal complications,
social and environmental factors that can affect neuro-
development, and had limited data on the role of HM
feeding on neurodevelopment of the group at greatest risk
for neurodevelopment impairment, namely children with
VLBW. The aim of this study is to systematically review
the original studies to determine whether there is a repro-
ducible independent effect of HM feeding on neurodeve-
lopment outcome in preterm VLBW infants.
Methods
Identification of articles
A systematic search of the literature was conducted for
studies published in English that examined the effect on
neurodevelopment and cognitive outcomes from breast
milk feeding to VLBW infants. Literature searches of the
databases Medline (via PubMed) from 1988, Cochrane
Library from 1982, Cumulative Index to Nursing and
Allied Health Literature (CINAHL) from 1992, Embase
from 1988, Proquest Research Library from1990, Google
Scholar from 1994, and Web of Science from 1992 were
performed on several occasions with a final search per-
formed on August 11, 2014.
The PubMed search strategy employed a 5 step process
using medical subject headings (mh) and related subject/
keyword/text word (tw) terms. The first 4 searches were
performed independently followed by the 5th search which
combined the results from first 4 searches within each
database to obtain the articles to be screened for relevance
and subsequent review. The first search include infant, pre-
mature (mh), OR infant, very low birth weight (mh) OR
Very low birth weight (tw) OR extremely low birth weight
(tw) OR preterm infants (tw). The second search include
breast feeding (mh) OR milk, human (mh) OR breast milk
(tw) OR donor milk (tw) OR donor human milk (tw) OR
maternal milk (tw). The third search include child develop-
ment (mh) OR cognition (mh) OR intelligence (mh) OR
neurodevelopment (tw) OR cognitive development (tw)
OR brain development (tw) OR cognitive outcomes (tw)
OR development cognitive (tw). The fourth search include
outcome (all fields) OR effect (all fields). The fifth search
combined the results from first 4 searches. This procedure
was followed for all databases except for some variation in
the search terms specific to a database.For the purpose of this review, “human milk” was
defined as breast milk from the mother (own mother’s
milk, OMM) or one or more donors (donor milk, DM),
whether it was delivered by gavage or a nipple from the
bottle or breast. “Neurodevelopment outcome” was
defined as the attainment of age-appropriate deve-
lopmental milestones or specific testing of intelligence
or educational achievement. Study outcome limited to
behavior/temperament tests or motor ability alone were
not considered since their value as the sole predictor
of long term neurodevelopment or cognitive function is
not well established.
Titles and available abstracts of all studies compiled
from the final electronic database search were screened
by the investigators to determine eligible studies. Peer
reviewed original studies independently assessed the re-
lationship between HM and neurodevelopment outcome
were identified. Reports of VLBW children studied as
part of a larger cohort of preterm children with greater
range of birth weights were included if the data clearly
delineated to allow assessment of neurodevelopment
effect on VLBW children from HM feeding. Bibliograph-
ies from these articles were also searched for additional
applicable studies. For each cohort with multiple publica-
tions, only the publication with the longest duration of
neurodevelopment follow-up was included in this review.
Evaluation of articles
We evaluated each article following the principles of
systematic review [12] and similar to previous reports
[8-10,13] but with modifications pertinent to the VLBW
situation. To minimize bias of this systematic review, each
study was evaluated independently by two authors (WK
and ST) according to a list generated a priori, and the final
result was a consensus reached by both authors.
To minimize bias within each study and across studies,
each study was reviewed according to a list of non-
nutritive and nutritive parameters. The non-nutritive
parameters included 1) study design and whether the
study’s primary goal was the determination of the effect
of breast milk on neurodevelopment or a secondary ana-
lysis in a non-breast milk related project, 2) target popu-
lation, whether VLBW infants were included as part of
the preterm population with higher birth weights or
were the sole target, 3) predetermined sample size for
different feeding groups, 4) whether adjustments were
made for baseline differences in other variables such as
the presence of intrauterine growth retardation (IUGR),
5) documentation of the extent of postnatal complica-
tions that could compromise the neurodevelopment out-
come including the extent of intracranial hemorrhage,
chronic lung disease, necrotizing enterocolitis, retino-
pathy of prematurity, severe neurosensory impairment,
documented sepsis; how this information was managed
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cluded from the data analysis, 6) control for bias in neu-
rodevelopment and cognitive outcome, namely whether
studies were controlled for socioeconomic status, ma-
ternal intelligence, and child rearing environment using
Child Life Experience [14], Home Observation for Mea-
surement of the Environment [15] or similar assessment
tool, 7) whether observers of the outcome were blind to
feeding status, 8) whether the study reported an effect
size or some other strategy to interpret the clinical im-
pact of the results. Nutritive parameters on the availa-
bility of feeding data included 1) definition and 2)
duration of HM intake, 3) the type and amount of forti-
fication, 4) source of HM feeding data, and the 5) type
of non-HM feeding support. To accommodate the varied
ages and circumstances of included children, all data
from standardized tests of neurodevelopment or general
intelligence were included. All quantitative and statistical
data presented were based on each publication without
any assumption or modification.
We also assessed the quality of each study [16] accor-
ding to study design, whether the methodological criteria
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Figure 1 Search strategy to obtain original studies assessing the effe
very low birth weight.Results
Figure 1 indicates the number of articles screened and
the final number of studies reviewed. A total of 24 re-
ports of original studies that included HM feeding and
neurodevelopment outcome in VLBW children were
identified. Thirteen reports were excluded as none of
these publications provided sufficient data to delineate
the effects of HM feeding on developmental outcome
of subjects with VLBW [11,17-28]. Of these 13 pu-
blications, six [11,22-26] were reports of selected subsets
(n = 50 to 438) from the same original study po-
pulations of 926 subjects. The average birth weights
were ~1400 g and 26 to 38% of the subjects were small
for gestation (SGA). Two population-based cohorts
[17,28] from the same country included >1400 preterm
infants in each cohort. The mean (SD) birth weights
of HM fed groups were 1430 (SD 280) g and 1460
(SD 400) g respectively. The birth weights were signi-
ficantly higher (average 100 g) and as was the mean
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Four of these publications were excluded because there
was another publication of the same cohort at a younger
age [36], no formal standardized neurodevelopment tests
were performed [37] and no suitable control group was
defined as the study involved supplementation of docosa-
hexaenoic acid and arachidonic acid of HM fed infants
[38,39]. Of the remaining 7 studies of VLBW children, 2
included only children with birth weights <1000 g [34,35].
Table 1 shows clinical characteristics of 7 studies of
developmental outcome associated with HM feeding in
VLBW infants. Three studies [30-32] reported the num-
ber of SGA infants with birth weight of <10th percentile
as surrogate for IUGR. SGA was reported to be as high
as 62% in one study [31]. The numbers of children from
multiple births also were not well documented.
Table 2 shows details of non-nutritive methodological
parameters. All were observational studies dependent on
maternal choice whether to provide breast milk with
varying amount of OMM provided to their VLBW in-
fant. In 6 of 7 studies, the effects of HM feeding on neu-
rodevelopment were extracted via secondary analysis of
data from other projects. The design of the primary
studies was epidemiologic observational with 2 interven-
tional studies: one on structured counseling to promote
breastfeeding [29] and the other on glutamine supple-
mentation in parenteral nutrition [35]. Three studies
[31,33,35] included only subsets of the study population
from primary study. Exclusion criteria were generally
clearly defined although varied among different studies.
Three studies [29,30,35] included children assessed at
younger than 3 years and 4 studies included children
from 5 to 11 years [31-34]. Sample sizes varied from 18
to 704 (median 219) children and none stated a priori
power calculation to measure the effect of breast milk.
The attrition rate of the subjects assessed tends to in-
crease with increased duration of follow-up. Blinding of
the observers to the feeding status of the subjects was
reported in 3 studies [29,30,34].
In all studies, VLBW children without neurological im-
pairment fed HM achieved normal or low normal scores
on standardized tests of neurodevelopment or cognitive
function. Thus any advantage of HM feeding is due to the
lower scores of formula-fed infants. Two studies [29,31]
used dichotomous grouping with 80% of the intake of HM
as a cutoff point. For the group that received the most
HM, one of these two studies reported a higher raw score
in one subtest of neurodevelopment at 5 years of age but
no adjustments were made to account for confounders
[31]. The other study showed no significant difference in
adjusted scores [29]. One study at 30 months corrected
age showed HM feeding during the hospitalization re-
sulted in mean Mental Developmental Index (MDI) and
Psychomotor Developmental Index (PDI) scores on theBayley Scales of Infant Development (BSID) in the low
normal range; those fed infant formula have significantly
lower scores [35]. Two of the 3 studies with neurode-
velopment assessment at 6 to 11 years showed that HM
feeding at highest volume was associated with intelligence
test scores in the normal range. The formula fed group
showed a significantly lower score in verbal intelligence
quotient (IQ) in one study [32] and in visual motor
skill subtest in another study [33]. The third study [34]
reported that children born extremely preterm without
major neurological impairment showed significantly poo-
rer academic attainment on reading and mathematics than
their term peers; HM feeding positively affected reading,
but not mathematics attainment, at 11 years. In the same
study, breast milk consumption together with perinatal
and neonatal complications and socio-economic status
accounted for 29% of the variance in reading attainment
at 11 years.
Table 3 shows every study obtained some data on peri-
natal, postnatal, social and environmental factors. How-
ever, the extent of the details varied greatly. The statistical
handling of the numerous variables also varied among
studies and only one study adjusted for the SGA status.
Table 4 shows the nutritive parameters assessed in each
study. Details on the extent and duration of HM feeding
varied. The source of the feeding data was referenced in 4
studies. Those with short-term follow-up generally had
sufficient details to allow categorization of the amount of
HM intake. Long-term follow-up studies generally relied
on maternal recall, and the amount of HM intake was not
quantified [31-34]. Only one study reported use of health
clinic record [32] as an additional measure to minimize
recall bias. No study reported the use of donor milk. Use
of HM fortifier was reported in 2 studies. Preterm infant
formula usage was reported in 3 studies but the type of
infant formula used was not documented in the other 4
studies. In 6 of 7 studies, the control group used as a com-
parison with HM-fed group was from the same cohort of
VLBW infants who were fed exclusively infant formula or
whose daily feedings consisted of up to 80% HM. Only
one study included children born at term and matched for
sex and ethnicity and attending the same mainstream
school or special education facility.
All but one study were secondary analyses of data from
primary studies that may have an independent effect on
neurodevelopment. The effect of HM on neurodevelop-
ment was based on observation of selected cohorts. The
quality and the risk of bias, as determined by the extent to
which the methodological parameters are met, were varied
among different studies (Table 5). Of the 8 non-nutritive
parameters, each study has at least 4 parameters that were
either not met or only partially met with the use of surro-
gate markers. Of the 5 nutritive parameters, one study did
not meet one parameter while the other studies did not
Table 1 Human milk (HM) and developmental outcome in very low birth weight (VLBW) infants: clinical characteristics
Reference Pinelli et al. [29] Furman et al. [30] Tanaka et al. [31] Horwood et al. [32] Smith et al. [33] Johnson et al. [34] Vohr et al. [35]
Birth weight g <1500 600-1499 <1500 <1500 <1500 <1000 <1000
Gestation: mean
(weeks, SD if available)
HM (29, 3) vs.
Control (29, 3).
All subjects (27, 2). HM (28.7, 3.2);
Control (30.7, 1.6).
* HM (28.7, 2.4) vs. Control
(27.8, 2.5).
HM <26 vs. Control (term birth). HM 26.7 vs. Control 26.2.
Range of HM intake >80% vs. <80% >50 to 0 mL/kg/d >80% vs. <80% Breastfeeding at discharge
vs. no HM at any stage
VLBW infants: any breast milk
vs. none during hospitalization.
Control: regardless of HM intake
>80% vs. 0
% small for gestation NS 8 HM 40%;
“Control” 62%
* NS NS NS
% singleton 100 100 NS * 61.5 NS NS
Year/s of birth NS Jan 1997-Feb 1999 1999-2000 1986 1991-1993 Mar-Dec 1995 Oct 99-Jun 2001
NS – not stated or specified.















Table 2 Human milk (HM) and developmental outcome in very low birth weight (VLBW) infants: non-nutritive methodological parameters
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Subject source One center, Canada One center, USA One center, Japan All VLBW births, New
Zealand




12 of 15 NICHD NRN
sites, USA










Cerebral palsy, no RBC





and no breast milk
data
NS None Unable to test
including those with
sensorineural deficit
Assessment age 6 and 12 m corrected 20 m corrected 5y 91 m 6 to 8y Median 10y 11 m 30 m corrected
Sample size
(assessed/eligible)*





Yes Yes NS NS NS Yes NS
Neurodevelopment
tests




KABC; TAAS; WIAT-II BSID-II
Effect size for
human milk†
See below See below See below See below See below See below See below
CI – confidence interval; NICHD NRN – National Institute of Child Health and Human Development Neonatal Research Network; NS – not stated or specified or not significant; RBC DHS red blood cell - Docosahexaenoic
acid; SD – standard deviation.
Neurodevelopment tests: BSID II Bayley Scales of Infant Development (2nd edition), MDI Mental Developmental Index, PDI Psychomotor Developmental Index; CCVL California Children’s Verbal Learning Test; CELF
Clinical Evaluation of Language Fundamentals 3rd ed; KABC - Kaufman Assessment Battery for Children; PPVT - Peabody picture vocabulary test 3rd ed; TAAS Teachers Academic Attainment Scale; WIAT-II Wechsler
Individual Achievement Test – II; WISC-R - Revised Wechsler intelligence scale for children; WRAVMA - Wide Range Assessment of Visual Motor Abilities.
*None had stated a priori power calculation to measure the neurodevelopment effect of HM. For Smith et al. [33], total sample size included 4 gestation matched VLBW controls for each VLBW subject with abnormal
cranial ultrasound. For Johnson et al. [34], control subjects included one subject selected randomly from 3 classmates born at term with same sex and ethnicity.
†Effect size for human milk (maximum amount or as specified) vs none or limited human milk. Mean (SD or CI if available) scores after adjustment for covariates and confounders:
Pinelli et al. [29]. Dichotomous groups based on 80% HM intake as cut point: No significant difference in MDI 92 (15) vs. 91 (12) or PDI 78 (15, SD) vs. 77 (14).
Furman et al. [30]. No significant difference in MDI 85 +/−21 vs. 80 +/−16 or PDI 76 +/−16 vs. 80 +/−16.
Tanaka et al. [31]. Dichotomous groups based on 80% HM intake as cut point: higher raw score for sequential 106.7 (14.5) vs. 94.7 (11.6) but not simultaneous or composite mental processing. No adjusted scores.
Horwood et al. [32]. Higher mean verbal IQ (102.1 vs 96.1 p < 0.05) and performance IQ (103.3 vs. 99.6, p > 0.15) after >8 m HM.
Smith et al. [33]. Significantly different in visual motor skills only: WRAVMA drawing 97.7 (14.6) vs. 90.6 (13.5), 95% CI = 1.0-9.2; and K-ABC triangle completion 10.6 (3.0) vs. 9.1 (2.5), 95% CI = 0.1-1.7. No HM effect from
increased HM duration (>4 m, in infants with abnormal cranial ultrasound or <28 weeks gestation).
Johnson et al. [34]. Regardless of HM intake, significantly lower composite scores in extremely preterm children without serious neurosensory or cognitive impairment for reading 91 (13.4) vs. 98.7 (11.5); for
mathematics 84.0 (15.6) vs. 98.8 (14.8). Data analyzed for children with and without serious functional or cognitive impairment while attending mainstream or special schools. Multivariate model show breast milk is
one of the independent predictors of reading scores but not mathematic scores at 11 years. Other independent predictors included BSID-II MDI, and head circumference at 30 m, and perinatal and social factors. All
independent predictors accounted for 31% of the variance for reading scores at 11 years.
Vohr et al. [35]. MDI and PDI in the highest 3 quintiles of human milk groups were higher (p <0.05) than no human milk group. Mean values for highest vs. no human milk for MDI 89.7 vs. 76.5, and for PDI 90.2 vs















Table 3 Human milk (HM) and developmental outcome in very low birth weight (VLBW) infants: perinatal, postnatal,
social and environmental data*
Reference Perinatal/postnatal factors Social and environmental factors
Pinelli et al. [29] Type of delivery Maternal and paternal age, education and
occupation, 1 or 2 parent home, social
classes I-V (Hollingshead index)
Furman et al. [30] Delivery at perinatal center, antenatal steroid
and cesarean section. Apnea, sepsis,
jaundice, necrotizing enterocolitis, chronic
lung disease, cranial ultrasound
abnormalities.
Maternal education and ethnicity, and
marital status
Tanaka et al. [31] Chronic lung disease, cranial ultrasound,
necrotizing entercolitis. Intrauterine growth
retardation
Maternal age and education
Horwood et al. [32] Sex, multiple births, birth weight, gestational
age, intrauterine growth retardation, 5 min
Apgar score
Maternal age, education and smoking, 1 or
2 parents, family income, child ethnicity,
birth order
Smith et al. [33] Length of hospital stay Maternal age, verbal ability, education,
cigarette smoking and marital status, Home
observation for measurement of the
environment inventory – short version,
annual household income, gender, parity
Johnson et al. [34] Birth weight, gestation, antenatal steroid,
premature rupture of membranes, vaginal
breech delivery, chorioamnionitis, admission
temperature <35°C, CRIB score, abnormal
last cranial ultrasound, necrotizing
entercolitis, postnatal steroid, duration of
NICU admission. Neurodevelopmental
assessment results at 30 m and 6 y
Socioeconomic (UK National Statistics
Socio-Economic classification), maternal age,
race and highest education.
Vohr et al. [35] Gestation, gender, sepsis, intraventricular
hemorrhage grade 3 to 4, periventricular
leukomalacia, oxygen need at 36 weeks,
necrotizing enterocolitis, and weight <10th
percentile at 18 months.
Maternal age and education, marital and
health insurance status, race, and income.
*The variables entered into the final model to determine the independent effect of HM feeding were varied and not always fully described. Some investigators
[30] used composite scores to minimize the number of variables entered into data analysis and no specific modeling was performed by other investigators [31].
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for a methodological parameter or the use of surrogate
markers negatively affected the quality of many studies.
Consistency of the effect is variable with the advantage of
feeding HM in adjusted neurodevelopment or educational
attainment test scores in 4 of the 7 reports [32-35]. Three
of these studies [32-34] of VLBW children at 6 to 11 years
of age showed an advantage from HM with selected sub-
tests rather than overall test scores. Dose effect of HM in-
take was reported with 2 studies [32,35]. Directness of the
outcome was supported with the use of age-appropriate
standardized tests but suffered from secondary analysis of
other studies, incomplete sampling, poor selection of con-
trol group, and use of surrogate markers.
Discussion
For infants born at term, the benefits of HM on neuro-
development and cognitive function may be limited ac-
cording to reports on studies that adequately controlled
for maternal intelligence and other social and environ-
mental factors [8-10]. HM may provide greater benefitfor the preterm infants when there is an added need for
specific nutrients and trophic effects. Meta-analysis of
earlier studies with larger preterm infants supported this
assumption [7]. However, the meta-analysis did not
attempt to evaluate each study’s methods or interpret re-
sults on the basis of the quality of the investigation. As a
result, the pooled effect estimates obtained reflect the
average of a heterogeneous group of studies.
Our systematic review on the independent effect of HM
feeding on neurodevelopment outcome, taking into ac-
count the additional confounders unique to VLBW chil-
dren, provided a better understanding of the strengths and
limitations of each study. It appears that significant limita-
tions exist with each study. These limitations may involve
study design or the quality of the study in the fulfillment of
non-nutritional and nutritional methodological criteria,
which can affect the applicability of the outcome data.
The inconsistent effect on neurodevelopment test scores
and variable advantage in different subtest scores when
assessed at school ages also contributed to the difficulty in
interpreting the HM effect on neurodevelopment outcome.
Table 4 Human milk (HM) and developmental outcome in very low birth weight (VLBW) infants: nutritive parameters
Reference Pinelli et al. [29] Furman et al. [30] Tanaka et al. [31] Horwood et al. [32] Smith et al. [33] Johnson et al. [34] Vohr et al. [35]
HM feeding definition.
None specified whether
donor milk was used.
Maternal milk intake as
% of total fluid intake and
by duration
Maternal milk at 0, 1–24,
25–49, >50 mL/kg/d
Maternal milk Any maternal milk
from birth
Expressed maternal
milk without or with
progression to direct
breastfeeding
Any breast milk Maternal milk
intake by quintiles
HM feeding duration Continuous measures till
12 m corrected
Up to 4w HM group 72 +/
− 45.2 (SD)d, Formula
group received HM for
59 +/−32.1d
None, <4 m, 4-7 m,
8 + m
<1w, 1-4w, 1-3 m, 4–6
m, >6 m
Neonatal period Up to 120d.
HM fortification Milk based powder if intake
<180-200 mL/kg/d
(21% of infants)
Milk based powder or
concentrated PTF




24 h expressed milk volume,
test weighing one feeding
each 3 m
* * Maternal recall and
child health record
Maternal recall * Database from
hospital records
Infant formula data 20 exclusively PTF PTF NS NS, n = 76 NS NS PTF, 180 (23%)
exclusively FF
PTF - Preterm formula in hospital, FF - formula fed, NS - not stated or specified.















Table 5 Studies of human milk (HM) feeding and developmental outcome in very low birth weight (VLBW) infants: meeting criteria for methodological quality
Reference Pinelli et al. [29] Furman et al. [30] Tanaka et al. [31] Horwood et al. [32] Smith et al. [33] Johnson et al. [34] Vohr et al. [35]
As primary outcome of original study* - + - - - - -
VLBW only + + + + + +† +†
A priori power calculation - - - - - - -
Baseline adjustment for SGA - - - + - - -
Postnatal complication - + - + - + +
Maternal intelligence +/− +/− +/− +/− +/− +/− +/−
Social class or Socioeconomic status + - - +/− +/− + +/−
Child rearing environment +/− +/− - +/− + - +/−
Observers blinded to feeding protocol + + - - - + -
Effect size after adjustment + + NA +‡ +‡ +‡ +‡
Human milk definition + + + + + + +
Human milk duration + + + + + + +
Human milk fortification + + - - - - -
Human milk feeding data source + - - + + - +
Formula type + + - - - - +
SGA = Small for gestational age, NA = not available.
+Met methodological criterion.
-Did not meet methodological criterion; or not stated or not specified in the publication.
+/−Use surrogates such as income for socioeconomic status, maternal education for maternal intelligence, marital status or one or two parent family for child rearing environment.
*All studies were observational and most were secondary analysis of study cohort from other studies.
†Only children with birth weights <1000 g.
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breast milk feeding on neurodevelopment in VLBW chil-
dren is based on observational data from other studies.
The source of VLBW population for example those with
postnatal complications [32,33]; and intervention per-
formed in the original studies, such as counseling to im-
prove breastfeeding [29] or glutamine supplementation
in parenteral nutrition [35] potentially may influence the
outcome measures by indirect means. Furthermore, se-
condary analysis of data generates more questions for
hypothesis testing rather than providing a definitive
cause and effect of HM feeding.
Quality of the studies, as indicated by adherence to
methodological criteria that minimizes risks for bias, is
generally low. Numerous factors other than nutritional
intake have been identified as confounding variables in
relation to child development [40] and may have origin
even before birth. Many preterm infants experienced
variable adverse growth in utero but not all studies re-
ported the rate of IUGR or SGA. In preterm infants,
SGA is an independent predictor of severe cognitive
deficit [17]. For extremely preterm infants with VLBW,
SGA as an indicator of IUGR has an odds ratio of 3.91
for increased risk of death or neurodevelopment impair-
ment [41]. Some studies of children born preterm have
reported IUGR or SGA rates from 34% [26] to as high as
60% [31], and not all studies reported whether or
how the data analysis accounted for IUGR or SGA. Extra
uterine growth retardation also occurs frequently in
VLBW infants and may be another marker for neuro-
development delay [42]. A small head circumference at
8 months corrected age is an independent marker of
neurodevelopment and cognitive impairment, indepen-
dent of the type of feeding [43,44]. Multiple births are at
risk for preterm delivery and discrepant in utero growth
resulting in VLBW and IUGR, and discordant neurode-
velopment outcome has been reported for VLBW twins
[45]. Not all studies have accounted for multiple births
and some studies have restricted the study population to
singletons [29,30]. In addition, the effect on breast milk
production in mothers with both twins admitted to a
neonatal intensive care unit is not well-defined.
For extremely preterm infants, a difference in 100 g in
birth weight or one week of gestation can have major
impact on perinatal and postnatal complications [46]
that can directly or indirectly impact neurodevelopment
outcome and confound the effects of HM. Thus it is im-
portant not to generalize the neurodevelopment effect of
HM from preterm infants with higher birth weight and
gestation, since they have a relatively longer period of
development in utero and less serious postnatal com-
plications. The earlier reports included large numbers of
preterm children with higher birth weights than VLBW
which could reflect better intrauterine growth at thesame gestation or had IUGR at a more advanced gesta-
tion [11,17-28]. Interaction between gender and diet has
been reported in some studies, with males showing more
benefit from nutritional intervention [11,26,34]. One
study of children with birth weight <1000 g reported
that being male has a small negative predictive effect on
reading but not mathematics attainment at 11 years [34].
The age at follow-up varies, although few studies
[32-34] assessed cognitive scores at school ages which
are considered as much better predictors of adult scores.
One report of significant positive effect of HM on neu-
rodevelopment at 30 months corrected age was gene-
rated from secondary analysis of a subpopulation from
another project [35]. In the same cohort, there was a
significant increase in MDI scores by 2.7 points in the
HM group and a trend to lower PDI scores by 2.3 points
in the non-HM group since an earlier assessment at
18 months [36]. This drift in test scores could bias the
outcome that showed HM group has higher MDI and PDI
scores at 30 months [35]. The advantage associated with
HM feeding appears to diminish with older children, as
the improvement in test scores is limited to selected and
different subtests [32-34]. It is possible that the effect of
HM may be less important as genetic and environmental
factors play bigger roles at school age. In some cohorts
with follow up at older ages, the validity of mother’s milk
effect on IQ at adolescence is questionable since the
data is based on <10% of the subjects from the original
cohort [22].
Age-appropriate developmental or cognitive tests
standardized to normal age matched children allow the
use of a control group from the same VLBW cohort
[29-33,35]. Only one study used selected classmates in
the same educational setting and born at term with same
sex and ethnicity and tested during the same period to
minimize any secular drift in test scores over time [34].
Selection of a control group based on the volume of hu-
man milk ingested heavily influences the outcome. Any
HM effect on neurodevelopment may be difficult to
detect when the data analysis is dichotomized using a
large volume of HM consumption as a cutoff point
[29,31]. Not all reports indicated whether the testers
were blind to feeding status thus contributing to the risk
for bias.
The extensive numbers of potential confounders of
neurodevelopment and variable exclusion criteria based
on the type and extent of postnatal complications sup-
port the need for appropriate statistical modeling and
large sample size to provide meaningful interpretation of
the neurodevelopment effect of feeding HM. One study
employed a composite neonatal risk score and a com-
posite socioeconomic score to minimize the number of
independent variables and to avoid multi-colinearity of
variables in statistical modeling [30]. However, there is
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the studies had stated a priori power calculation to
measure the neurodevelopment effect of HM.
Both breastfeeding and neurodevelopment outcome are
confounded by maternal intelligence, social and socioeco-
nomic status, and child rearing environment, and possibly
from intangible psychobiology of maternal behavior and
mother-infant relationship [10,47,48]. Mothers elected to
provide HM and breastfeeding are often highly motivated
and possibly more health conscious and more likely to
stimulate their infants thus contributing to self-selection
bias. None of the studies reviewed have formal assessment
of maternal intelligence and few studies specifically as-
sessed the other confounders. The use of surrogate for
these critical independent determinants of neurodevelop-
ment outcome limits the validity of HM effect.
It is important to recognize that VLBW children with
no neurological impairment and fed HM achieved normal
or low normal scores on standardized tests of neuro-
development or cognitive function. The VLBW children
fed a lower amount of HM or fed infant formula have
lower test scores. One should consider feeding HM as
protective rather than providing an added advantage to
neurodevelopment.
Nutritive factors are important in the evaluation of the
role of HM in neurodevelopment and cognitive function
of VLBW children. In a cohort of children born preterm
and including those with VLBW enrolled in a quasi-
randomized study of supplementing OMM with DM or
infant formulas, preliminary data at 7.5 to 8 years from
the first 300 children out of 926 subjects showed that
the children who received OMM had IQ scores in the
normal range. However, those who exclusively received
formula have overall test scores that were 8.3 points
lower [11]. In a subsequent report of 377 subjects from
several subsets in the same cohort of infants, those who
received infant formula (nutrient enriched versus regular
formula), and either exclusively or as a supplement to
OMM, experienced a beneficial effect to neurodevelop-
ment that appeared primarily to be related to the use of
the nutrient enriched formula [26]. Unfortunately, no
quantifiable data specific to VLBW children was pre-
sented in either report.
In the studies reviewed, the contents of nutrients in
infant formulas and HM fortifiers are in much lower
quantity and lack additional nutrients such as LCPUFA
when compared to the current formulations. If better
nutrient profile is critical to neurodevelopment, then it
is possible that all VLBW infants could benefit with the
use of newer and better fortified formulas and HM
fortifiers.
The timing, volume and duration of HM consumed
could be important for neurodevelopment. Significant
advantage in neurodevelopment effect appears to occureven after a brief period of consumption of OMM du-
ring initial hospitalization as >88% of infants in one
study [11] and 77% of infants in another study [35] re-
ceived no HM by the time of hospital discharge. Unfor-
tunately, these details are extremely limited in long-term
follow-up studies.
A dose effect of OMM also may be present. Preterm
infants whose mothers intended to breastfeed but could
not provide any breast milk, performed at the level of
exclusively formula fed children on cognitive testing at
7.5 to 8 years [11], and a dose effect was also de-
monstrated when the analysis was performed with HM
intake as a continuum [35]. One long-term VLBW po-
pulation cohort at 7 to 8 years of age showed a signifi-
cant benefit of prolonged breastfeeding and reached a
mean of 6 points advantage in verbal IQ after receiving
OMM for 8 months or more [32]. However, no ad-
ditional benefit beyond 4 months of breastfeeding was
reported in another study of VLBW children at 6 years
[33]. A modest independent beneficial effect of feeding
OMM during the neonatal period on higher reading but
not mathematics attainment at 11 years was also re-
ported [34].
It is important to determine whether OMM or DM was
used in the assessment of HM’s effect on neurodevelop-
ment. Fresh OMM contains many components that may
provide trophic actions which can directly or indirectly
influence the growth and development of the nervous sys-
tem but are inactivated or destroyed during processing of
the DM [6,49]. The use of DM alone or as supplement to
OMM resulted in poorer growth and neurodevelopment
[23]. It appears that VLBW children in all studies reviewed
were provided with OMM; none reported that any DM
was used. The use of HM fortifiers was reported in two
studies [29,30]. In another study, the use of human milk
fortifier was not specified but was likely provided since
the cohorts were born in the era when HM fortification
was the standard of care [35].
It is possible that space limitation imposed by the jour-
nals may have precluded detail description by the inves-
tigators, although it is unlikely to eliminate all significant
limitations that exist with each study. Limitations to our
study included at least the following: we evaluated ori-
ginal peer reviewed studies only in English and did not
pursue details from published abstracts or the authors.
However, abstracts have not undergone the same rigor
in review process as the full publication and are unlikely
to have sufficient data to allow meaningful systematic
review of the data. Information from the authors is un-
likely to resolve the many methodological concerns in
the studies reviewed, and additional information would
be unlikely to alter the overall conclusions. Our study
also excluded 13 reports [11,17-28] because of insuffi-
cient data to delineate the effect of HM feeding on
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The data from these reports included many children
with higher birth weights and thus at lower risk of
neurodevelopment deficit than VLBW children. Further-
more, reports based on subsets of original cohort make
it difficult to interpret the significance of the finding in
the context of the whole population and should be con-
sidered as hypothesis generating rather than definitive
data on the neurodevelopment benefit of HM.
In addition, the two population observational studies
[17,28] were confounded by the HM fed cohorts having
significantly greater birth weights and gestations com-
pared to non HM group. In any case, the neurodevelop-
ment scores in those fed predominantly OMM [11,17-28]
are generally within the normal ranges and consistent with
reports that include only children with VLBW [29-35].Conclusions
There is no randomized clinical trial comparing the
neurodevelopment outcome of HM versus formula or
minimal HM feeding that included only children with
VLBW. Studies to date have significant methodological
limitations although limited data suggest a possible pro-
tective effect on neurodevelopment from feeding OMM
for a short period after birth and a possible dose effect
on the volume and duration of feeding OMM. If better
overall nutrient profile is more important for optimal
neurodevelopment, it is theoretically possible that the
use of current formulations of HM fortifier and preterm
infant formulas could improve the neurodevelopment
outcome of all VLBW children. Thus, the role of mater-
nal milk in neurodevelopment and cognitive function of
VLBW infants needs to be reassessed with high quality
studies in the context of current formulations of HM
fortifier and preterm formula. With increasing use of
DM to the exclusion of preterm formula in NICU, a
separate assessment of the role of DM in neurodevelop-
ment is needed in view of the numerous differences bet-
ween OMM and DM.
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